Infectious Disease & Pathology Research

 

At Houston Methodist, our investigators follow many areas of leading-edge infectious disease research — molecular mechanisms of pathogenesis, human genetics of susceptibility to infectious agents, vaccine development, and prevention of hospital-acquired infections — to discover innovations that improve clinical practice. We conduct our research in state-of-the-art facilities using genome-wide analysis methods and high-throughput technologies.

Recent Highlights
Our facilities include a biosafety level 3 laboratory, confocal microscopes, gene expression microarray biochip stations and ABI sequencing capabilities. Our researchers help combat the tremendous toll infectious diseases take on human morbidity and mortality by exploring a diverse range of pathogens, including Streptococcus A and B, Mycobacterium tuberculosis, and Staphylococcus aureus, to name a few.
Unveiling the Secret Life of Flesh-Eating Bacteria
Houston Methodist infectious disease researchers created a genetic roadmap of how group A strep causes flesh-eating disease.
Rapid TB Screening Nanofilms: nanotraps

Precisely engineered technology uses silica nanopore thin films to isolate Mycobacterium tuberculosis antigens in clinical samples for rapid TB screening.

James Musser, MD, PhD Becomes FASEB President

James Musser, MD, PhD, is the 2018-2019 president of the Federation of American Societies for Experimental Biology (FASEB).

hurricane
Hope for Hurricane Victim of Flesh-Eating Bacteria
Houston Methodist researchers offer hope for treatment of flesh-eating bacteria contracted from hurricane floodwaters.

65

Peer-reviewed Publications in 2023

44

Active Clinical Protocols

24

Full-Time Faculty

Explore the following:

Donate to Houston Methodist

With your support, Houston Methodist provides exceptional research, education, and care that is truly leading medicine.

Donate Now